Diabetes

Papers
(The H4-Index of Diabetes is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking113
983-P: Long-Term Improvement in CGM-Measured Glycemic Control in Adults with Type 2 Diabetes Not Treated with Insulin—Real-World Data107
1082-P: Online Clinician Education Results in Performance Changes in Clinical Practice Related to Obesity Management in Patients With and Without Type 2 Diabetes97
1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases87
2054-LB: Mitigating Adipose Tissue Dysfunction and Insulin Resistance in Obesity via SVEP1 Peptide-Mediated Suppression of Adipose Tissue Macrophage-Induced Inflammation82
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Di78
1682-P: Factors Associated with Postprandial Suppression of Endogenous Glucose Production in People without Diabetes73
1708-P: Development of a Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery68
71-OR: ADA Presidents' Select Abstract: HLA-Focused Meta-Genetic Risk Score (GRS) Performance in Populations of Diverse Ancestry with Type 1 Diabetes62
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)61
1478-P: Polygenic Risk Score Predicts Incident Cardiovascular Disease in People with Diabetes at Borderline or Intermediate 10-Year ASCVD Risk51
249-OR: Cystatin C Predicts Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with and among Those without Type 2 Diabetes51
2037-LB: Considerations for Calculating and Reporting CGM Wear-Time in Research Settings46
468-P: Association between Sudomotor Function and Coronary Atherosclerosis in Patients with Type 2 Diabetes45
1638-P: Oxidized Lipids Cause Ceramide Accumulation and Insulin Resistance in Skeletal Muscle44
261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education44
1740-P: Regulation of Endocrine Cell Alternative Splicing Revealed by Single-Cell RNA Sequencing in Type 2 Diabetes41
697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients41
921-P: Impact of Heart Rate and Step Count on Deep Learning Glucose Prediction Models during Physical Activity41
1558-P: Immunological Role of Hybrid Insulin Peptide in Type 1 Diabetes in Asia40
1591-P: Effects of Light Exposure during Sleep on Glycemic Control in Type 1 Diabetes40
727-P: A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells39
1586-P: Association between PCSK7 Levels and NAFLD Severity in KADEM Study39
562-P: A Social Media Intervention Shows Promise to Improve Health Outcomes in Low-Income Immigrants with Type 2 Diabetes—Evidence from a Pilot RCT38
1641-P: Effect of Specific Weight-Reducing Interventions on Metabolic and Immunological Outcomes in Mice38
280-OR: Insulin Sensitivity following an In-Home Sleep and Circadian Intervention for Habitually Short-Sleeping Adolescents38
633-P: Insight to the Association between Serum Fibroblast Growth Factor 23 Levels and Presarcopenia in Nondiabetic Individuals—A Longitudinal Cohort Study38
478-P: Application of Plasma Proteomics to Explore Potential Biomarkers of Diabetic Macular Edema38
718-P: A High FODMAP Diet Reduces Glycemic Excursion without Increasing Gastrointestinal Symptoms in Individuals with Prediabetes Treated with Metformin—A Randomized Crossover Controlled-Feeding Trial37
1358-P: Diabetes Prediction without Blood Tests—The Role of Retinal Imaging and Artificial Intelligence37
1478-P: Incidence and Glucose Trends among Patients with Acute Stroke and Stress Hyperglycemia—Insights from a Descriptive Analysis36
99-OR: AgRP Neuron Hyperactivity Drives Hyperglycemia in a Mouse Model of Type 2 Diabetes36
1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)35
643-P: Exploring Eating Styles of Older Adults with Type 1 Diabetes (T1D)35
366-P: Machine Learning Reveals CGM Superiority over Hypoglycemia Awareness Questionnaires in Discriminating Individuals with Severe Hypoglycemia35
121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study35
0.4595160484314